[Elsevier] Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study

Mos272 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-18 01:05
Reward30points

Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled studyEfficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study - The Lancet

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00865-2/abstract










Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
PhDScholar2045 Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    185


Daily Top Contributors

Return to the list